Travere Therapeutics Stock (NASDAQ: TVTX) stock price, news, charts, stock research, profile.
Open | $9.93 |
Close | $9.89 |
Volume / Avg. | 672.63K / 1.19M |
Day Range | 9.69 - 10.12 |
52 Wk Range | 5.12 - 17.57 |
Market Cap | $752.92M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 67 |
Short Interest | 14.93% |
Days to Cover | 8.54 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Travere Therapeutics (NASDAQ:TVTX) through any online brokerage.
Other companies in Travere Therapeutics’s space includes: Celcuity (NASDAQ:CELC), Replimune Group (NASDAQ:REPL), Mesoblast (NASDAQ:MESO), Olema Pharmaceuticals (NASDAQ:OLMA) and Emergent BioSolutions (NYSE:EBS).
There is no analysis for Travere Therapeutics.
Travere Therapeutics has a consensus price target of $20.73.
The stock price for Travere Therapeutics (NASDAQ: TVTX) is $9.89 last updated July 26, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Travere Therapeutics.
Travere Therapeutics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Travere Therapeutics.
Travere Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.